BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2005
View Archived Issues
Avicinylation helps fight oxidative and nitrosative stress
Read More
Update on the efficacy of once-weekly exenatide LAR in type 2 diabetes
Read More
New clinical evidence supports the use of oxymorphone ER in chronic pain
Read More
MedImmune licenses rights from GSK to BSYX-A110
Read More
Long-term benefits of rimonabant in overweight/obese patients
Read More
TAP Pharmaceutical to develop Takeda's TAK-390MR for acid disorders
Read More
Cardiome Pharma to acquire Artesian Therapeutics
Read More
NeuroSearch and TopoTarget expand collaboration with NSD-551
Read More
PDE4 inhibitor GRC-3886 named oglemilast, set to enter phase II in 2006
Read More
Nippon Chemiphar and Cerenis sign license agreement for PPARdelta agonists
Read More
Early close out of SIMPADICO trial of Celcade
Read More
Pivotal study begins for CPI-226 for prevention of catheter-related infections
Read More
Enrollment 90% complete in phase IIIb malignant mesothelioma study of Onconase
Read More
Amplimexon receives U.S. orphan drug status for ovarian cancer
Read More
CGX-1160 designated orphan drug for chronic intractable pain
Read More
Modulation of plasminogen pathways may cause rofecoxib-associated cardiovascular complications
Read More
GW-493838X: preclinical and clinical update
Read More
New title added to the Drug R&D Backgrounders topic list - Actinic Keratosis
Read More
Final results from the PROMPT study confirm the benefits of epoetin alfa in CKD patients with anemia
Read More
Belatacept found as effective and better tolerated than ciclosporin in renal transplant recipients
Read More
Isatoribine induces antiviral effects in patients with chronic hepatitis C
Read More
Bristol Myers seeks Japanese approval for Baraclude
Read More
Increlex approved for short stature caused by severe primary IGF-1 deficiency
Read More
New clinical data supports the use of methylnaltrexone in opioid-induced constipation
Read More
sBLA filing for Rituxan in rheumatoid arthritis
Read More
Recent patents cover novel treatments for psychiatric disorders
Read More
Novel therapeutics for neurological disorders reported in recent patent literature
Read More
GABA-B receptor agonists prepared and tested at Bayer
Read More
Novel selective alpha4beta7/MAdCAM-1 antagonist reduces inflammation in mice with colitis
Read More
XEN-2174: efficacious against morphine tolerant neuropathic and incisional pain
Read More
Novel PPARgamma inverse agonist GSK-5737 effective in preclinical models of diabetes
Read More